SCHEMBL16624324

SCHEMBL16624324

CCOc1ccc(Cc2c(C)nc(N)nc2C)c(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
LMNA P02545 2/20 0.46
KMT2A Q03164 4/20 0.43
ATM Q13315 1/20 0.43
DHFR P00374 4/20 0.42
NPSR1 Q6W5P4 1/20 0.41
TSHR P16473 3/20 0.41
TP53 P04637 2/20 0.40
CYP3A4 P08684 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 3/20 0.39
NPC1 O15118 2/20 0.39
APOBEC3G Q9HC16 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 1/20 0.38
CASP3 P42574 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16624326 0.91 KMT2A (0.44) SMN1; SMN2KDM4EHPGDLMNAKMT2A
SCHEMBL16624329 0.87 NPSR1 (0.40) KMT2AATMDHFRNPSR1
SCHEMBL16624328 0.80 NPSR1 (0.37) KMT2AATMDHFRNPSR1TSHR
SCHEMBL16624325 0.78 NPSR1 (0.40) SMN1; SMN2DHFRNPSR1NPC1RAB9A
SCHEMBL16624354 0.77 TLR7 (0.41) SMN1; SMN2KDM4EKMT2ADHFRNPSR1
SCHEMBL16624319 0.74 DHFR (0.41) DHFRNPSR1
SCHEMBL16624362 0.72 HSP90AB1 (0.41) SMN1; SMN2DHFR
SCHEMBL13110336 0.72 NQO1 (0.52) KDM4EHPGDLMNAKMT2ATSHR
SCHEMBL3701139 0.72 TLR7 (0.64)
SCHEMBL16624352 0.72 DHFR (0.39) KMT2ADHFRALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160251319-A1 CARBOXYLIC ACID COMPOUNDS SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2016-09-01 US disclosed
US-9376398-B2 Carboxylic acid compounds SUMITOMO DAINIPPON PHARMA CO., LTD (JP) 2016-06-28 US disclosed
US-20150099770-A1 CARBOXYLIC ACID COMPOUNDS Sumitomo Pharma Co., Ltd. (JP) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099770-A1 CARBOXYLIC ACID COMPOUNDS C9, SUCNR1, C3AR1 SMN1; SMN2 1872/4885KDM4E 2508/4885HPGD 1058/4885
US-20160251319-A1 CARBOXYLIC ACID COMPOUNDS C9, SUCNR1, C3AR1 SMN1; SMN2 1872/4885KDM4E 2508/4885HPGD 1058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.